LifeMD, Inc. — Director's Dealing 2021

Feb 5, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: CONVERSION LABS, INC. (CVLB)
CIK: 0000948320
Period of Report: 2021-02-03

Reporting Person: Deutsch Corey (Chief Business Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Options to purchase shares of Common Stock	$		Common Stock, par value $0.001 (25000)		Direct
Options to purchase shares of Common Stock	$		Common Stock, par value $0.001 (175000)		Direct

Footnotes

F1: On February 3, 2021 (the "Effective Date"), Mr. Deutsch and the Issuer entered into First Amendment to Employment Agreement (the "Amended Employment Agreement"), whereby Mr. Deutsch was appointed Chief Business Officer of the Issuer. As of the Effective Date, the Board of Directors of the Issuer has acknowledged the role of Chief Business Officer as an executive officer position.

F2: Pursuant to the terms of the consulting agreement, by and between Mr. Deutsch and the Issuer, dated December 3, 2020, Mr. Deutsch was granted stock options to purchase up to 25,000 shares of the Company's common stock at an exercise price of $8.25 per share (the "Consultancy Stock Options"). The Consultancy Stock Options vested on December 3, 2020.

F3: Pursuant to the terms of the employment agreement, by and between Mr. Deutsch and the Issuer, dated January 14, 2021, Mr. Deutsch was granted stock options to purchase up to 175,000 shares of the Company's common stock at an exercise price of $7.07 per share (the "Stock Options"). The Stock Options shall vest in equal monthly tranches, based on the passage of time, over the 36 months, beginning on the Effective Date.